Assessing the content based on ICF and quality based on COSMIN criteria of patient-reported outcome measures of functioning in breast cancer survivors: a systematic review Farkhondeh JamshidiMaryam FarzadMojtaba Habibi Asgarabad Review Article 01 March 2022 Pages: 377 - 393
Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis Miyako NaraSakiko IshiharaHideko Yamauchi Review Article 25 February 2022 Pages: 394 - 401
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review Salvatore FicarraEwan ThomasHande Hofmann Review Article Open access 12 March 2022 Pages: 402 - 418
Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy F. M. NimbiS. MagnoR. Tambelli Original Article 06 January 2022 Pages: 419 - 428
Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study Elena LeinertLukas Schwentnerthe BRENDA study group Original Article Open access 18 February 2022 Pages: 429 - 436
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study Giuditta CarrettiDaniela MirandolaMirca Marini Original Article 13 January 2022 Pages: 437 - 449
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction Peng GaoXiangyu WangJing Wang Original Article 03 January 2022 Pages: 450 - 457
Multi-time scale transcriptomic analysis on the dynamic process of tamoxifen resistance development in breast cancer cell lines Qiuhong ZengXiaofang LinXianlong Wang Original Article 18 January 2022 Pages: 458 - 467
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer Anli YangMinqing WuXin An Original Article Open access 21 January 2022 Pages: 468 - 477
Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: where and when to measure is optimal? Jiong-Hui GuChang HeTian-An Jiang Original Article 17 January 2022 Pages: 478 - 486
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow Lisa GrüntkemeierAditi KhuranaSabine Kasimir-Bauer Original Article Open access 13 January 2022 Pages: 487 - 497
Is adjuvant chemotherapy necessary in older patients with breast cancer? Midori MoritaAkihiko ShimomuraToru Higuchi Original Article Open access 15 January 2022 Pages: 498 - 506
BC-DETECT: combined detection of serum HE4 and TFF3 improves breast cancer diagnostic efficacy Mohamed A. AbdelrazekAhmed NagebRizk Elbaz Original Article 07 January 2022 Pages: 507 - 515
BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion Ze-yu YangSu-peng YinHongdan Chen Original Article 19 January 2022 Pages: 516 - 530
Modification of oncoplastic breast surgery with immediate volume replacement using a thoracodorsal adipofascial flap Munetsugu HirataHiroko TodaYuko Kijima Original Article Open access 04 February 2022 Pages: 531 - 540
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer Md. Nazim UddinXiaosheng Wang Original Article 12 January 2022 Pages: 541 - 561
CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors Daniela NasifSebastian RealMaría T. Branham Original Article 30 January 2022 Pages: 562 - 573
